(MENAFN- Ameliorate Digital Consultancy) According to a new report by Fact.MR, a market research and competitive intelligence provider, the global central venous catheters (cvcs) market is expected to reach a valuation of US$ 1.6 billion by 2026.

The market for central venous catheters is expanding as a result of an increase in the number of competent physicians & nurses and the rising preference for various treatment modalities that are both efficient and affordable. Increased research to cure nosocomial infections, better antimicrobial catheter quality, and more people using CVCs for parenteral nutrition & fluid therapy are prominent aspects boosting the sales of central venous catheters.

Download a Sample Copy of This Report:

Rising incidence of cancer, changing lifestyles, hereditary factors, and growing use of parenteral nourishment are all contributing to the growth of the CVCs market. Market growth is also being fueled by the development of minimally-invasive procedures and a rise in the number of knowledgeable workers.

Increasing acceptance and demand for antimicrobial coated catheters, along with socioeconomic reasons, including increased illness rates because of an ageing population, are key drivers for worldwide CVCs market growth.

Which Factors Could Adversely Impact Sales of Central Venous Catheters?

“High Cost of Central Venous Catheters & Presence of Alternative Vascular Access Devices”

The market would be constrained over the forecast period by certain consequences, including injury to central veins, pulmonary difficulties, cardiac problems, device malfunction, catheter-related bloodstream infections, and the growing popularity of alternative vascular access devices.

Additionally, it is anticipated that the decline in blood transfusions will impede the expansion of the global market for central venous catheters. Over the projected period, the rising number of central venous catheter recalls is projected to restrain the growth of the global central venous catheters market.

The high price of advanced catheters, however, might impede business development. A growing proportion of patients undergoing catheterization operations need innovative central venous catheters because they have chronic and cardiovascular disorders such as urine bladder, renal failure, and coronary heart disease.

However, the adoption rate of central venous catheters may decline across low-income countries as a result of the expensive catheterization operations for these disorders.

Key Segments Covered in the Central Venous Catheters Industry Survey

• By Design :
  • Multi-Lumen
  • Triple-Lumen
  • Double-Lumen
  • Single-Lumen

• By Property :
  • Non-antimicrobial Coated
  • Antimicrobial Coated

• By Application :
  • Jugular Vein
  • Femoral Vein
  • Subclavian Vein
• By End User :
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• By Region :
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Winning Strategy

Market players are concentrating on introducing antimicrobial-coated catheters and increasing their R&D activities to reduce bloodstream infections. Manufacturers of central venous catheters are placing greater emphasis on investments in product quality and design to reduce hazards and guarantee patient safety.

Market participants are working to receive regulatory authority recommendations regarding the classification of central venous catheters, and this is anticipated to drive market growth substantially over the coming years.

For instance,

• In 2020, for detection, monitoring, and analysis of the radiofrequency and energy delivery during cardiac ablation treatments, Boston Scientific Corporation introduced the DIRECTSENSE technology tool, which is implanted at the tip of a catheter.

Get Customization on Central Venous Catheters Market Report for Specific Research Solutions

Key players in the Central Venous Catheters Market

• Amecath
• Medtronic Plc
• Smiths Medical, Inc.
• Teleflex Incorporated
• Vygon Ltd.
• ZOLL Medical Corporation
• AngioDynamics Inc.
• B. Braun Melsungen AG
• Bactiguard AB
• Becton, Dickinson and Company

Key Takeaways from Central Venous Catheters Market Study

• The global CVCs market is currently valued at US$ 1.3 billion.
• Market in Germany projected to increase at CAGR of 5% through 2026.
• Market in Japan anticipated to rise at 4.5% CAGR over forecast period.
• Sales of triple-lumen central venous catheters expected to increase at CAGR of 5.5% from 2022 to 2026.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail:

MENAFN29072023004660010643ID1106731971